Quarterly report [Sections 13 or 15(d)]

Preferred Stock and Stockholders' Equity (Details)

v3.26.3
Preferred Stock and Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 08, 2026
Apr. 27, 2026
Sep. 30, 2026
Jun. 30, 2026
Sep. 30, 2026
Dec. 31, 2025
Subsidiary or Equity Method Investee [Line Items]            
Preferred stock, shares authorized (in shares)     10,000,000   10,000,000  
Preferred stock, par value (in dollars per share)     $ 0.0001   $ 0.0001  
Contingent Shares     100,000   100,000  
Put Option            
Subsidiary or Equity Method Investee [Line Items]            
Derivative Asset     $ 0   $ 0  
Security Purchase Agreement Warrants            
Subsidiary or Equity Method Investee [Line Items]            
Class of Warrants, Percentage of Outstansing Shares Issuable   0.66333%        
Expected term of warrants (in years)   7 years        
Securities Purchase Agreement Warrants            
Subsidiary or Equity Method Investee [Line Items]            
Warrant issued for securities (in shares)     900,000   900,000  
Exercise price (in dollars per share)     $ 10.73   $ 10.73  
Warrants fair value   $ 21,500        
Series D Preferred Stock            
Subsidiary or Equity Method Investee [Line Items]            
Preferred stock, shares authorized (in shares)     1,100,000   1,100,000  
Preferred stock, par value (in dollars per share)     $ 0.0001   $ 0.0001  
Preferred Stock, Dividend Rate, Percentage   19.50%     19.50%  
Series D-1 Preferred Stock            
Subsidiary or Equity Method Investee [Line Items]            
Preferred stock, shares authorized (in shares)     1,100,000   1,100,000 1,100,000
Preferred stock, par value (in dollars per share)     $ 0.0001   $ 0.0001 $ 0.0001
Preferred Stock, Dividend Rate, Percentage         19.50%  
Class A Common Stock | Securities Purchase Agreement D-1 Warrants            
Subsidiary or Equity Method Investee [Line Items]            
Warrant issued for securities (in shares) 700,000          
Exercise price (in dollars per share) $ 8.98          
Warrants fair value $ 4,700          
D1- Units            
Subsidiary or Equity Method Investee [Line Items]            
Unrealized Gain (Loss) on Derivatives     $ (2,900)      
D1- Units | Put Option            
Subsidiary or Equity Method Investee [Line Items]            
Derivative Asset   $ 0 2,900   $ 2,900  
Unrealized Gain (Loss) on Derivatives     0   8,100  
Private Placement            
Subsidiary or Equity Method Investee [Line Items]            
Sale of Stock, Number of Shares Authorized for Issuance in Transaction, Value   $ 70,000        
Sale of Stock, Consideration Received on Transaction     18,700 $ 51,300    
Private Placement | D1- Units            
Subsidiary or Equity Method Investee [Line Items]            
Sale of Stock, Consideration Received on Transaction $ 14,000          
Sale of Stock, Remaining Units, Value     $ 56,000   $ 56,000  
Derivative, Fair Value, Net       $ 2,900